NCT06087510View on ClinicalTrials.gov

Different Dose Esketamine and Dexmedetomidine for Supplemental Analgesia and Longterm Outcomes

PHASE4RecruitingINTERVENTIONAL
Enrollment

312

Participants

Timeline

Start Date

January 24, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

September 30, 2026

Conditions
Scoliosis CorrectionPostoperative AnalgesiaEsketamineDexmedetomidineChronic Postsurgical Pain
Interventions
DRUG

Esketamine

Different doses of esketamine in the esketamine-dexmedetomidine combination as a supplement to sufentanil for postoperative analgesia.

Trial Locations (1)

100034

RECRUITING

Beijing University First Hospital, Beijing

All Listed Sponsors
lead

Peking University First Hospital

OTHER